Algeta Files in Norway

Algeta ASA, an < ?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" />Oslo, Norway-based developer of anticancer radiopharmaceuticals, has filed for an IPO on the Oslo Stock Exchange. ABG Sundal Collier and DnB NOR Markets have been named co-lead financial advisors and Terra Securities is co-lead manager. Algeta has raised around $34 million in VC funding from firms like Advent Venture Partners, NorgesInvestor, Odlander Fredrikson & Co., S.R. One Ltd. and Selvaag Invest.